Tag Archives: During

Newer Anti-HIV Drugs Safest, Most Effective During Pregnancy

Dolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study of pregnant women. UNC’s Lameck Chinula presented findings at the 2020 Conference on Retroviruses and Opportunistic Infections. UNC’s Jeffrey Stringer is a study investigator. The antiretroviral drugs dolutegravir and emtricitabine/tenofovir alafenamide fumarate (DTG+FTC/TAF) may comprise the safest and most effective HIV treatment regimen currently available… Read More »

Assistance during first years of biology major leads to higher retention of first-gen students

For many young college students, the first years are a time of wonder and excitement and early steps toward long-term goals. These years, for some students, are equally fraught with anxiety, as the realities of rigorous curricula set in alongside feelings of unpreparedness and impostor syndrome. In the STEM fields, this results in roughly 50%… Read More »

Second case of unintended HIV transmission during HIV cure study prompts questions about PrEP provision

A second case of HIV transmission from someone interrupting their HIV therapy as part of a cure study has been published. The report, by Dr Ainoa Ugarte, Dr Lorna Leal and colleagues from Barcelona University Hospital (Ugarte reference below) has prompted discussion about whether the HIV-negative partners of people involved in studies that feature so-called analytical treatment interruptions… Read More »